Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
retinoic acid receptor alpha | 0.470 | 0.846 | 0.96 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 1992 | 1994 | ||||||||
|
HLF transcription factor, PAR bZIP family member | 0.628 | 0.615 | 0.95 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 1991 | 1995 | |||||||||
|
opioid receptor kappa 1 | 0.555 | 0.615 | 4.1E-05 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
upstream transcription factor 2, c-fos interacting | 0.626 | 0.654 | 0.99 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 1996 | 1996 | ||||||||
|
alpha-methylacyl-CoA racemase | 0.510 | 0.769 | 2.7E-02 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 1996 | 1996 | ||||||||
|
Leukemia, acute lymphocytic, susceptibility to, 1 | 0.636 | 0.269 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 1994 | 1998 | |||||||||
|
phosphoglycolate phosphatase | 0.606 | 0.808 | 0.16 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
small cell cancer of the lung | 0.612 | 0.577 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | |||||||||
|
proteasome 20S subunit beta 6 | 0.561 | 0.731 | 1.6E-02 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 1993 | 2001 | ||||||||
|
delta like canonical Notch ligand 1 | 0.492 | 0.808 | 1.00 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 1993 | 2001 | ||||||||
|
YY1 transcription factor | 0.481 | 0.808 | 0.99 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 1993 | 2001 | ||||||||
|
H3 histone pseudogene 9 | 0.505 | 0.731 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2001 | |||||||||
|
nuclear transport factor 2 like export factor 1 | 0.505 | 0.731 | 0.65 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2001 | ||||||||
|
SUB1 regulator of transcription | 0.465 | 0.846 | 0.89 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2001 | ||||||||
|
mitochondrial ribosomal protein L28 | 0.505 | 0.731 | 2.0E-07 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2001 | ||||||||
|
PML-RARA regulated adaptor molecule 1 | 0.700 | 0.462 | 3.0E-04 |
|
phenotype | 0.100 | None | 1.000 | 15 | 0 | 1993 | 2002 | ||||||||
|
TAL bHLH transcription factor 1, erythroid differentiation factor | 0.505 | 0.731 | 0.57 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 1993 | 2002 | ||||||||
|
afadin, adherens junction formation factor | 0.650 | 0.462 | 1.00 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2000 | 2002 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2002 | |||||||||
|
suppression of anchorage independence 1 | 0.560 | 0.615 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | |||||||||
|
S100 calcium binding protein A4 | 0.448 | 0.769 | 6.2E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
tyrosinase | 0.473 | 0.808 | 5.0E-32 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
acidic nuclear phosphoprotein 32 family member B | 0.541 | 0.731 | 0.96 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
TNF superfamily member 13 | 0.499 | 0.769 | 0.82 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 |